164 related articles for article (PubMed ID: 19687577)
21. Combined Associations of Liver Enzymes and Obesity With Diabetes Mellitus Prevalence: The Tohoku Medical Megabank Community-based Cohort Study.
Itabashi F; Hirata T; Kogure M; Narita A; Tsuchiya N; Nakamura T; Nakaya N; Sasaki R; Takanashi N; Sakata K; Tanno K; Sugawara J; Kuriyama S; Tsuji I; Kure S; Hozawa A
J Epidemiol; 2022 May; 32(5):221-227. PubMed ID: 33390464
[TBL] [Abstract][Full Text] [Related]
22. Association of gamma-glutamyl transferase and alanine aminotransferase with type 2 diabetes mellitus incidence in middle-aged Japanese men: 12-year follow up.
Kaneko K; Yatsuya H; Li Y; Uemura M; Chiang C; Hirakawa Y; Ota A; Tamakoshi K; Aoyama A
J Diabetes Investig; 2019 May; 10(3):837-845. PubMed ID: 30204299
[TBL] [Abstract][Full Text] [Related]
23. Increased liver markers are associated with higher risk of type 2 diabetes.
Ko SH; Baeg MK; Han KD; Ko SH; Ahn YB
World J Gastroenterol; 2015 Jun; 21(24):7478-87. PubMed ID: 26139993
[TBL] [Abstract][Full Text] [Related]
24. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.
Ruhl CE; Everhart JE
Gastroenterology; 2009 Feb; 136(2):477-85.e11. PubMed ID: 19100265
[TBL] [Abstract][Full Text] [Related]
25. Considering serum alanine aminotransferase and gamma-glutamyltransferase levels together strengthen the prediction of impaired fasting glucose risk: a cross-sectional and longitudinal study.
Jeong JH; Jung S; Kim KN
Sci Rep; 2021 Feb; 11(1):3333. PubMed ID: 33564044
[TBL] [Abstract][Full Text] [Related]
26. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.
Nakanishi N; Suzuki K; Tatara K
Diabetes Care; 2004 Jun; 27(6):1427-32. PubMed ID: 15161799
[TBL] [Abstract][Full Text] [Related]
27. Markers of the hepatic component of the metabolic syndrome as predictors of mortality in renal transplant recipients.
Zelle DM; Corpeleijn E; van Ree RM; Stolk RP; van der Veer E; Gans RO; Homan van der Heide JJ; Navis G; Bakker SJ
Am J Transplant; 2010 Jan; 10(1):106-14. PubMed ID: 19951280
[TBL] [Abstract][Full Text] [Related]
28. Combined Effect of Initial and Longitudinal Increases in γ-Glutamyltransferase on Incident Metabolic Syndrome: ARIRANG Study.
Yadav D; Lee MY; Kim JY; Ryu H; Huh JH; Bae KS; Ahn SV; Chung CH; Park JT; Koh SB
Yonsei Med J; 2017 Jul; 58(4):763-769. PubMed ID: 28540989
[TBL] [Abstract][Full Text] [Related]
29. Alanine aminotransferase, gamma-glutamyltransferase (GGT) and all-cause mortality: results from a population-based Danish twins study alanine aminotransferase, GGT and mortality in elderly twins.
Fraser A; Thinggaard M; Christensen K; Lawlor DA
Liver Int; 2009 Nov; 29(10):1494-9. PubMed ID: 19686309
[TBL] [Abstract][Full Text] [Related]
30. Relationship between serum gamma-glutamyltransferase levels and prehypertension in Chinese adults: the cardiometabolic risk in Chinese study.
Zhu Y; Gong Y; Zhu R; Liu XK; Sun YT; Wang Y; Qi L; Liang J
J Clin Hypertens (Greenwich); 2014 Oct; 16(10):760-5. PubMed ID: 25113653
[TBL] [Abstract][Full Text] [Related]
31. Impact of metabolic syndrome on elevated serum alanine aminotransferase levels in the Japanese population.
Saito T; Nishise Y; Makino N; Haga H; Ishii R; Okumoto K; Ito JI; Watanabe H; Saito K; Takeda H; Togashi H; Kubota I; Daimon M; Kato T; Kawata S
Metabolism; 2009 Aug; 58(8):1067-75. PubMed ID: 19411086
[TBL] [Abstract][Full Text] [Related]
32. Role of GGT in diagnosis of metabolic syndrome: a clinic-based cross-sectional survey.
Kasapoglu B; Turkay C; Bayram Y; Koca C
Indian J Med Res; 2010 Jul; 132():56-61. PubMed ID: 20693590
[TBL] [Abstract][Full Text] [Related]
33. The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome.
Steinvil A; Shapira I; Ben-Bassat OK; Cohen M; Vered Y; Berliner S; Rogowski O
Cardiovasc Diabetol; 2010 Jul; 9():30. PubMed ID: 20633271
[TBL] [Abstract][Full Text] [Related]
34. Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) in serum: results from an IFCC multicenter study.
Ceriotti F; Henny J; Queraltó J; Ziyu S; Özarda Y; Chen B; Boyd JC; Panteghini M; ;
Clin Chem Lab Med; 2010 Nov; 48(11):1593-601. PubMed ID: 21034260
[TBL] [Abstract][Full Text] [Related]
35. Increase in gamma-glutamyltransferase level and development of established cardiovascular risk factors and diabetes in Japanese adults.
Jimba S; Nakagami T; Oya J; Wasada T; Endo Y; Iwamoto Y
Metab Syndr Relat Disord; 2009 Oct; 7(5):411-8. PubMed ID: 19419267
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016.
Denova-Gutiérrez E; Lara-Castor L; Hernández-Alcaraz C; Hernández-Ávila M; Aguilar-Salinas C; Kershenobich D; Barquera S
Ann Hepatol; 2021 Dec; 26():100562. PubMed ID: 34653686
[TBL] [Abstract][Full Text] [Related]
37. Serum gamma-glutamyltransferase is inversely associated with dietary total and coffee-derived polyphenol intakes in apparently healthy Japanese men.
Taguchi C; Kishimoto Y; Kondo K; Tohyama K; Goda T
Eur J Nutr; 2018 Dec; 57(8):2819-2826. PubMed ID: 28988315
[TBL] [Abstract][Full Text] [Related]
38. Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus.
Zhang Y; Lu X; Hong J; Chao M; Gu W; Wang W; Ning G
Endocrine; 2010 Oct; 38(2):181-7. PubMed ID: 20972737
[TBL] [Abstract][Full Text] [Related]
39. Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome.
Sogabe M; Okahisa T; Kurihara T; Takehara M; Kagemoto K; Okazaki J; Kida Y; Hirao A; Tanaka H; Tomonari T; Taniguchi T; Okamoto K; Nakasono M; Takayama T
PLoS One; 2020; 15(8):e0238388. PubMed ID: 32866186
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome.
Forlani G; Di Bonito P; Mannucci E; Capaldo B; Genovese S; Orrasch M; Scaldaferri L; Di Bartolo P; Melandri P; Dei Cas A; Zavaroni I; Marchesini G
J Endocrinol Invest; 2008 Feb; 31(2):146-52. PubMed ID: 18362506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
